102.50
전일 마감가:
$100.91
열려 있는:
$101.4
하루 거래량:
6.01M
Relative Volume:
0.70
시가총액:
$151.88B
수익:
$19.35B
순이익/손실:
$2.78B
주가수익비율:
54.82
EPS:
1.8696
순현금흐름:
$3.82B
1주 성능:
+3.70%
1개월 성능:
+7.43%
6개월 성능:
-0.35%
1년 성능:
+15.85%
보스턴사이언티픽 Stock (BSX) Company Profile
명칭
Boston Scientific Corp
전화
508-683-4000
주소
300 BOSTON SCIENTIFIC WAY, MARLBOROUGH, MA
BSX을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
|
BSX
Boston Scientific Corp
|
102.50 | 149.59B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
ABT
Abbott Laboratories
|
127.00 | 218.91B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
SYK
Stryker Corp
|
363.70 | 135.77B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
95.40 | 118.85B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
85.16 | 48.79B | 5.88B | 1.34B | 799.60M | 2.3489 |
보스턴사이언티픽 Stock (BSX) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2025-10-03 | 다운그레이드 | Erste Group | Buy → Hold |
| 2025-09-08 | 업그레이드 | Oppenheimer | Perform → Outperform |
| 2025-06-16 | 개시 | Leerink Partners | Outperform |
| 2025-04-16 | 업그레이드 | Needham | Hold → Buy |
| 2025-01-10 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2024-10-18 | 다운그레이드 | Needham | Buy → Hold |
| 2024-05-30 | 개시 | Goldman | Buy |
| 2024-02-01 | 업그레이드 | Mizuho | Neutral → Buy |
| 2023-07-19 | 개시 | Robert W. Baird | Outperform |
| 2023-06-30 | 개시 | CL King | Buy |
| 2023-05-30 | 재개 | Morgan Stanley | Overweight |
| 2023-03-29 | 개시 | UBS | Buy |
| 2022-12-22 | 개시 | Mizuho | Neutral |
| 2022-12-20 | 재개 | Citigroup | Buy |
| 2022-10-18 | 개시 | Barclays | Overweight |
| 2022-10-12 | 개시 | Jefferies | Buy |
| 2022-07-06 | 개시 | Wolfe Research | Outperform |
| 2022-05-27 | 업그레이드 | Needham | Hold → Buy |
| 2022-04-13 | 재개 | Truist | Buy |
| 2022-03-02 | 재개 | BofA Securities | Buy |
| 2021-12-10 | 개시 | RBC Capital Mkts | Outperform |
| 2021-05-26 | 다운그레이드 | Needham | Buy → Hold |
| 2021-05-25 | 개시 | Barclays | Overweight |
| 2021-04-15 | 개시 | Atlantic Equities | Overweight |
| 2020-09-17 | 개시 | Truist | Buy |
| 2020-09-11 | 개시 | Wolfe Research | Peer Perform |
| 2020-04-22 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2020-04-01 | 업그레이드 | Goldman | Neutral → Buy |
| 2020-03-05 | 개시 | Citigroup | Buy |
| 2020-02-13 | 개시 | Goldman | Neutral |
| 2020-02-06 | 재개 | BTIG Research | Buy |
| 2019-12-30 | 재확인 | Cowen | Outperform |
| 2019-12-19 | 다운그레이드 | Needham | Strong Buy → Buy |
| 2019-09-05 | 재개 | JP Morgan | Overweight |
| 2019-09-03 | 재개 | Barclays | Overweight |
| 2019-05-13 | 업그레이드 | Evercore ISI | In-line → Outperform |
| 2018-11-28 | 개시 | UBS | Buy |
| 2018-10-16 | 개시 | Barclays | Overweight |
| 2018-10-02 | 재확인 | Morgan Stanley | Overweight |
| 2018-09-07 | 재확인 | Needham | Strong Buy |
| 2018-09-04 | 업그레이드 | Jefferies | Hold → Buy |
| 2018-07-06 | 재확인 | Needham | Strong Buy |
| 2018-06-27 | 개시 | Bernstein | Outperform |
| 2018-04-26 | 재확인 | Needham | Strong Buy |
모두보기
보스턴사이언티픽 주식(BSX)의 최신 뉴스
CLOSURE-AF study not the end of the line for LAAC devices - BioWorld MedTech
Can Boston Scientific Corporation recover in the next quarter2025 Buyback Activity & Verified Short-Term Trading Plans - newser.com
Using AI based signals to follow Boston Scientific Corporation2025 Sector Review & Risk Adjusted Buy and Sell Alerts - newser.com
What earnings revisions data tells us about Boston Scientific CorporationMarket Trend Review & AI Driven Stock Reports - newser.com
What's Behind Boston Scientific's Optimism for Urology Growth? - Nasdaq
Technical signs of recovery in Boston Scientific CorporationGDP Growth & AI Forecast Swing Trade Picks - newser.com
Does Boston Scientific Corporation stock trade at a discount to peersWeekly Gains Summary & Risk Adjusted Buy/Sell Alerts - newser.com
Boston Scientific announces 2025 Investor Day meeting and conference call discussing third quarter 2025 results - Quantisnow
Boston Scientific Corporation (BSX) Stock Price | Live Quotes & Charts | NYSE - StocksToTrade
Can Boston Scientific Corporation stock sustain revenue momentumTrade Exit Report & Safe Capital Growth Tips - newser.com
Elutia Q3 2025 slides: $88M Boston Scientific deal reshapes strategy amid revenue dip - Investing.com
Insider Sell: Ellen Zane Sells Shares of Boston Scientific Corp (BSX) - GuruFocus
Boston Scientific director Zane sells $1.26 million in stock - Investing.com
[Form 4] BOSTON SCIENTIFIC CORP Insider Trading Activity - Stock Titan
Boston Scientific Corporation (BSX) Stock forecasts - Yahoo! Finance UK
Boston Scientific Corporation (BSX) Stock Forecasts - Yahoo Finance
[144/A] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Can Boston Scientific Corporation stock test all time highsMarket Rally & Weekly Top Stock Performers List - newser.com
Boston Scientific (BSX): Evaluating Valuation After Strong Q3 Results and New Product Launches - Yahoo Finance
Top FDA clearances not to be missed - Modern Healthcare News
Boston Scientific Corp. (BSX) Stock Price Prediction: 2025, 2026, 2030: Analyst Targets & Forecast - Benzinga
Main Street Research LLC Has $40.96 Million Stock Holdings in Boston Scientific Corporation $BSX - MarketBeat
Homestead Advisers Corp Has $81.57 Million Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Fullcircle Wealth LLC Takes Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific EVP Joseph Michael Fitzgerald Sells 50,000 Shares - TradingView
Global Pain Management Devices Market Set to Expand Rapidly at a CAGR of ~8% by 2032 Amid Growing Preference for Minimally Invasive Solutions | DelveInsight - GlobeNewswire Inc.
Bank of New York Mellon Corp Has $1.20 Billion Stake in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific Corporation stock ready for a breakoutJuly 2025 Update & Fast Gain Stock Trading Tips - newser.com
Beyond the Balance Sheet: What SWOT Reveals About Boston Scienti - GuruFocus
Boston Scientific Corp. stock underperforms Monday when compared to competitors - MarketWatch
[144] BOSTON SCIENTIFIC CORP SEC Filing - Stock Titan
Boston Scientific (NYSE: BSX) to join Wolfe and Citi events; webcasts Nov. 18 and Dec. 2 - Stock Titan
iA Global Asset Management Inc. Buys 9,476 Shares of Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Machina Capital S.A.S. - MarketBeat
[10-Q] BOSTON SCIENTIFIC CORP Quarterly Earnings Report | BSX SEC FilingForm 10-Q - Stock Titan
BOSTON SCIENTIFIC CORP SEC 10-Q Report - TradingView
Sumitomo Life Insurance Co. Sells 6,543 Shares of Boston Scientific Corporation $BSX - MarketBeat
Wakefield Asset Management LLLP Purchases New Position in Boston Scientific Corporation $BSX - MarketBeat
October M&A: Bristol Myers, Thermo Fisher, Hologic and Boston Scientific - The Business Journals
Is Boston Scientific Corporation stock a smart buy before Fed meetingWeekly Profit Summary & Verified Swing Trading Watchlist - newser.com
Risk vs reward if holding onto Boston Scientific Corporation2025 Major Catalysts & Smart Money Movement Alerts - newser.com
Do Wall Street Analysts Like Boston Scientific Stock? - MSN
Gould Asset Management LLC CA Takes $1.10 Million Position in Boston Scientific Corporation $BSX - MarketBeat
Boston Scientific Corporation $BSX Position Boosted by Assetmark Inc. - MarketBeat
Boston Scientific Corporation $BSX Shares Sold by Atria Investments Inc - MarketBeat
World Investment Advisors Raises Stock Position in Boston Scientific Corporation $BSX - MarketBeat
What market sentiment indicators show for Boston Scientific Corporation stockM&A Rumor & Safe Entry Zone Identification - newser.com
Boston Scientific Corporation $BSX Shares Sold by GAM Holding AG - MarketBeat
Lockheed Martin Investment Management Co. Lowers Stock Position in Boston Scientific Corporation $BSX - MarketBeat
Is Boston Scientific (BSX) Becoming the Leading MedTech Growth Story? - Insider Monkey
Adell Harriman & Carpenter Inc. Has $4.89 Million Position in Boston Scientific Corporation $BSX - MarketBeat
보스턴사이언티픽 (BSX) 재무 분석
매출
순이익
현금흐름
주당 순 이익
자본화:
|
볼륨(24시간):